SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ImmunityBio converts from Immunomedics
IBRX 2.139+0.9%Nov 7 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: luckydog88 who wrote (861)1/31/2025 3:57:47 PM
From: bobbseytwins20017 Recommendations

Recommended By
Davidoff
End2War
Fitzhughlaw
JJINV
luckydog88

and 2 more members

  Read Replies (1) of 1230
 
You fellows obviously do care to discuss politics here despite the disclaimers, but the purpose of this forum is to discuss the prospects for IBRX. It is true that PSS is the heart of the company, but he has the choice to support who he hopes to become head of the FDA, and probably he is acting in his own self interest, which happens to be our self interest as well. It seems to us that it would be somewhat self destructive at the least to take a stand against the new FDA head when you want FDA to support your technology. Anyway the social scientist in the op-ed is just another person with an opinion, and everyone has one. Meanwhile IBRX seems to be doing fine fundamentally, and we are far more interested in soon to be reported fourth quarter revenues, which we suspect will top the numbers floating around out there.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News